510(k) K924006

BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY by Baxter Healthcare Corp — Product Code GNX

K924006 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on December 29, 1992. The device falls under product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 29, 1992
Date Received
August 10, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
Device Class
Class I
Regulation Number
866.3330
Review Panel
MI
Submission Type